Table 2.
Chloroquine/Hydroxychloroquine (147) |
Anti‐viral drugs |
Lopinavir/Ritonavir (70) |
Favipiravir (24) |
Umifenovir (15) |
Remdesivir (11) |
Sofosbuvir (1) |
Darunavir (1) |
Ritonavir (1) |
Oseltamivir (1) |
Protein kinase inhibitors |
Ruxoltinib (13) |
Baricitinib (5) |
Imatinib (2) |
Anti‐infective agents |
Azytromicin (55) |
Anticoagulants |
Enoxaparin (5) |
Anti‐inflammatory drugs |
In brackets No. of ongoing trials. Data from Ref. 9 to 46.